READERS' COMMENTSEffects of Intravenous Glucagon-Like Peptide-1 on Glucose Control and Hemodynamics After Coronary Artery Bypass Surgery in Patients With Type 2 Diabetes

摘要

We read with interest the report by Sokos et al on better glycemic control and comparable hemodynamic recovery without the requirement for high-dose insulin or inotrope due to the perioper-ative use of glucagon-like peptide-1 (GLP-1) after coronary- artery bypass grafting (CABG). Although in the study by Sokos etal, only2ofthe lOpatients treated with GLP-1 had diabetes, these results indicate that GLP-1 is an attractive treatment for hyperglycemia in diabetic patients who undergo CABG.